Market Currents

• Tuesday, March 10, 2009

• 10:16 AM Unprofitable Momenta Pharmaceuticals (MNTA) may become the first drugmaker to win U.S. clearance to sell generic versions of biotech medicines. Shares +6.9%. Comment!

• Thursday, January 15, 2009

• 09:04 AM Cypress Bioscience (CYPB +39%) and Forest Labs (FRX +7.5%) get FDA approval for Savella in fibromyalgia treatment. Other stocks that could see an FDA bump: AMAG Pharma (AMAG), BioDelivery Sciences (BDSI), Momenta Pharma (MNTA). (more) Comment!